The Global Pharmaceutical Industry
DOWNLOAD
Download The Global Pharmaceutical Industry PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get The Global Pharmaceutical Industry book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Pfizer And The Challenges Of The Global Pharmaceutical Industry
DOWNLOAD
Author : Axel Jörn
language : en
Publisher: Anchor Academic Publishing
Release Date : 2016-07
Pfizer And The Challenges Of The Global Pharmaceutical Industry written by Axel Jörn and has been published by Anchor Academic Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-07 with Business & Economics categories.
This Case Study defines the global pharmaceutical industry and its „boundaries“, analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters’ Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore, it explains and evaluates Pfizer’s new strategy and examines what Pfizer did in the recent years to maintain their profitability.
The Global Pharmaceutical Industry
DOWNLOAD
Author : Daniel Hoffman
language : en
Publisher: Routledge
Release Date : 2020-07-06
The Global Pharmaceutical Industry written by Daniel Hoffman and has been published by Routledge this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-07-06 with Business & Economics categories.
The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between filling a prescription, paying for housing, and buying food. This has brought about public pressure on governments around the world to control drug prices, yet the world’s twenty largest pharma companies realized 80% of their growth as a result of exorbitant price hikes. Pharma currently enjoys its extraordinary profitability by exploiting the world’s most vulnerable populations. Yet even their ability to increase prices in the face of falling demand does not satisfy their profit demands. The breadth and depth of pharma’s marketing transgressions exceed those of any other industry and have now reached a point where authorities around the world have found it necessary to take legal action against its violations. Drastic change is needed if the pharmaceutical industry can equitably advance the health of the world’s population and regain public esteem. This book illustrates the range and extent of pharma’s violations and addresses the actions that should be implemented in order to make the drug industry a more constructive, less venal part of contemporary society. It will be of interest to researchers, academics, practitioners, and students with an interest in the pharmaceutical industry, healthcare management, regulation, and bioethics.
The Global Pharmaceutical Industry
DOWNLOAD
Author : Hank Laskey
language : en
Publisher: Xlibris Us
Release Date : 2019-11-08
The Global Pharmaceutical Industry written by Hank Laskey and has been published by Xlibris Us this book supported file pdf, txt, epub, kindle and other format this book has been release on 2019-11-08 with Business & Economics categories.
This book uniquely combines the study of business and economics with the study of medicine, science, and technology--all within a regulatory framework--and provides the reader with a broad perspective necessary to understand the multifaceted global pharmaceutical industry. It provides a solid introduction for anyone who desires to enter or excel within the industry today yet also provides a fascinating historical perspective for those interested in economics and business development on a global scale.
Global Competitiveness In The Pharmaceutical Industry
DOWNLOAD
Author : Madhu Agrawal
language : en
Publisher: CRC Press
Release Date : 1999-09-03
Global Competitiveness In The Pharmaceutical Industry written by Madhu Agrawal and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 1999-09-03 with Medical categories.
Examine the global pharmaceutical industry and the effect of national, regulatory, economic, and market environments on the competitiveness of the industry! This unique book is the only empirical study that examines the effects of the national environment on the competitiveness of a country's pharmaceutical industry. This informative book explores such topics as the types of comparative advantages that firms use for developing competitive advantages and what strategic choices firms should make when collaborating with international firms. Public policy implications with respect to the economic environment are also discussed to give you a complete look at the international pharmaceutical industry. Global Competitiveness in the Pharmaceutical Industry recognizes pharmaceutical industries as being of great social and public importance to all countries, since so many life saving drugs have emerged from pharmaceutical laboratories over the past four decades. By helping to combat many fatal diseases and eradicate others, drug producers have helped to positively alter mortality patterns in many parts of the world, thus making companies compete to provide many important medicines. The unique research presented in this book examines the determinants of global competitive advantage in the pharmaceutical industry by answering such questions as: Which factors stimulate or inhibit a nation's pharmaceutical industry to be globally innovative? Which factors stimulate or inhibit diffusion of pharmaceutical innovations (NECs) into its markets? Are there differences between industrialized and developing countries with respect to factors that affect innovation and global competitiveness in the pharmaceutical industry? Global Competitiveness in the Pharmaceutical Industry makes several theoretical, empirical, and methodological contributions which lead to results and generate important managerial and public policy implications. You will find a comprehensive overview of the nature of global competition in the pharmaceutical industry and its evolution in the post World War II period. Global Competitiveness in the Pharmaceutical Industry provides you with an in-depth understanding of the dynamics and importance of the global pharmaceutical market.
Global Pharmaceutical Policy
DOWNLOAD
Author : Frederick M. Abbott
language : en
Publisher: Edward Elgar Publishing
Release Date : 2009-01-01
Global Pharmaceutical Policy written by Frederick M. Abbott and has been published by Edward Elgar Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-01-01 with Law categories.
There is a strong argument that people throughout the world have a right to receive the medicines they need in an appropriate, affordable, and timely way. Global Pharmaceutical Policy describes the laws, policies, and customs relating to the development and provision of medicines, identifies their strengths and weakness, and then proposes global solutions for getting things better. Here is a masterpiece written in a clear and elegant style. Together, Dukes and Abbott have experience and insight that are unrivalled. Joe Collier, Emeritus Professor of Medicines Policy, St George s, University of London, UK Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world s poor see little effort to address diseases prevalent in less affluent societies, while the world s wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.
Mergers And Acquisitions In The Global Pharmaceutical Industry
DOWNLOAD
Author : Mennen
language : en
Publisher: GRIN Verlag
Release Date : 2010-12-17
Mergers And Acquisitions In The Global Pharmaceutical Industry written by Mennen and has been published by GRIN Verlag this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010-12-17 with Business & Economics categories.
Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger’s outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey’s five step programme will be discussed.
The Global Pharmaceutical Industry In The 1990s
DOWNLOAD
Author : Barrie G. James
language : en
Publisher:
Release Date : 1990
The Global Pharmaceutical Industry In The 1990s written by Barrie G. James and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Business & Economics categories.
Global Pharmaceuticals
DOWNLOAD
Author : Adriana Petryna
language : en
Publisher: Duke University Press
Release Date : 2006-03-15
Global Pharmaceuticals written by Adriana Petryna and has been published by Duke University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006-03-15 with Business & Economics categories.
DIVAnthropological study of the globalization of pharmaceuticals and its effects on local cultures, health, and economics./div
Global Health Partnerships
DOWNLOAD
Author : Mei-Ling Wang
language : en
Publisher: Springer
Release Date : 2008-11-28
Global Health Partnerships written by Mei-Ling Wang and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008-11-28 with Business & Economics categories.
An exploration into the current status and future growth of the global pharmaceutical industry and the changing needs of global health. It provides comprehensive coverage of the role of the global pharmaceutical industry in general, and the participation of BRICAs in specific, to address global health needs.
Prescription Games
DOWNLOAD
Author : Jeffrey Robinson
language : en
Publisher: McClelland & Stewart
Release Date : 2001
Prescription Games written by Jeffrey Robinson and has been published by McClelland & Stewart this book supported file pdf, txt, epub, kindle and other format this book has been release on 2001 with Business & Economics categories.
The major pharmaceutical companies, according to John le Carré – who has based his novel The Constant Gardener on their depredations – “are engaged in the systematic corruption of the medical profession, country by country.” Jeffrey Robinson can back up that charge. In Prescription Games, Jeffrey Robinson exposes the yawning abyss between the claims to altruism made by pharmaceutical companies and the harsh reality of their everyday practice. When the industry claims that the enormous markup they charge for new drugs pays the cost of developing new ones, they don’t say that as much as 80 per cent of R&D money is actually directed at developing drugs designed to compete with existing brands, or at creating variations on drugs whose patents are about to expire – expenditures only the industry itself (and its shareholders) will benefit from. Within the industry, there are “blockbuster” drugs that create vast wealth for the companies that manufacture them. Most are designed to treat conditions that are endemic among prosperous, western populations that can afford them. But there are no blockbuster drugs to treat diseases like tuberculosis, cholera, and malaria that ravage the Third World, because Third World countries can’t afford the prices. People in Africa and Asia die from new strains of tuberculosis while people in Europe and North America are offered expensive treatments for obesity, hair loss, and sexual dysfunction. In this hard-hitting exposé, Robinson also examines the extension of patent protection, the end of generic drug competition in Canada, the Nancy Olivieri scandal (how a drug manufacturer fought to conceal research findings that would damage sales of its product), the illicit drug trade, and espionage among drug manufacturers.